Coherus Biosciences | CHRS - Trade Creditors

Stock Price
1.61
Daily Change
-0.40 -19.90%
Monthly
0.63%
Yearly
36.44%
Q1 Forecast
2.39

Coherus Biosciences reported $24.89M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Akebia Therapeutics USD 10.09M 1.47M Sep/2025
ALKERMES USD 68M 31.21M Sep/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 36.71M 8M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Baxter International USD 999M 46M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 24.89M 12.73M Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Fujifilm JPY 308.06B 17.41B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Ironwood Pharmaceuticals USD 1.61M 224K Sep/2025
Merck USD 4.15B 102M Sep/2025
Myriad Genetics USD 31.8M 900K Sep/2025
Pacira USD 17.69M 12.44M Sep/2025
Perrigo USD 469.7M 19.3M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xencor USD 9.08M 9.45M Sep/2025
Zoetis USD 487M 77M Dec/2025